Geert Meersseman
- Virology top 5%
- HIV Research and Treatment 3
- Molecular Biology top 10%
- Genomics and Chromatin Dynamics 8
- RNA and protein synthesis mechanisms 7
- DNA and Nucleic Acid Chemistry 5
- Biochemical and Molecular Research 3
- RNA Research and Splicing 3
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 3
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Sari PenningsE. Morton BradburyInès ChevoletTeofila SeremetSofie WilgenhofGeert MaertensYanina JansenBart Neyns
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nucleic Acids Research (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- BelgiumUnited StatesAlgeria
In The Last Decade
Geert Meersseman
17 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Virology 137
- Molecular Biology 1.1k
- Infectious Diseases 156
- Cancer Research 121
- Structural Biology 6
Countries citing papers authored by Geert Meersseman
This map shows the geographic impact of Geert Meersseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Meersseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Meersseman more than expected).
Fields of papers citing papers by Geert Meersseman
This network shows the impact of papers produced by Geert Meersseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Meersseman. The network helps show where Geert Meersseman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Geert Meersseman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 116 | |
| 2 | 2016 | 9 | |
| 3 | 2015 | 14 | |
| 4 | 2015 | 1 | |
| 5 | 2012 | 5 | |
| 6 | 2011 | 5 | |
| 7 | 2008 | 139 | |
| 8 | 2004 | 93 | |
| 9 | 2004 | 19 | |
| 10 | 1997 | 64 | |
| 11 | 1995 | 29 | |
| 12 | 1995 | 24 | |
| 13 | 1994 | 142 | |
| 14 | 1992 | 20 | |
| 15 | 1992 | 265 | |
| 16 | 1991 | 118 | |
| 17 | 1991 | 168 | |
| 18 | 1989 | 41 |
About Geert Meersseman
Geert Meersseman is a scholar working on Virology, Molecular Biology and Infectious Diseases, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (8 papers), RNA and protein synthesis mechanisms (7 papers), DNA and Nucleic Acid Chemistry (5 papers), HIV Research and Treatment (3 papers), Biochemical and Molecular Research (3 papers), Cancer Genomics and Diagnostics (3 papers), HIV/AIDS drug development and treatment (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Virology (137 citations), Molecular Biology (1.1k citations) and Infectious Diseases (156 citations). Geert Meersseman has collaborated with scholars based in Belgium, United States and Algeria. Frequent co-authors include Sari Pennings, E. Morton Bradbury, Inès Chevolet, Teofila Seremet, Sofie Wilgenhof, Geert Maertens, Yanina Jansen, Bart Neyns, Max Schreuer and Bart Jacobs. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.